Arthur M. Cohen & Associates’s Agios Pharmaceuticals AGIO Stock Holding History

Arthur M. Cohen & Associates’s Portfolio AGIO Stock Details AGIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-3,171	Closed	-$111K	–	143
2020 Q3	$111K	Buy	+3,171	New	+$139K	0.03%	135
2019 Q2	–	Sell	-7,612	Closed	-$513K	–	117
2019 Q1	$513K	Hold	7,612	–	–	0.18%	71
2018 Q4	$587K	Hold	7,612	–	–	0.19%	67
2018 Q3	$587K	Hold	7,612	–	–	0.18%	71
2018 Q2	$641K	Hold	7,612	–	–	0.24%	61
2018 Q1	$560K	Hold	7,612	–	–	0.21%	65
2017 Q4	$351K	Buy	+7,612	New	+$479K	0.1%	83
2017 Q2	$397K	Buy	+7,612	New	+$389K	0.16%	77
2014 Q3	$508K	Buy	+7,612	New	+$328K	0.24%	71

Other funds holding AGIO

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return

Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

Arthur M. Cohen & Associates's AGIO Position: Q4 2020 in Review

Arthur M. Cohen & Associates sold out of Agios Pharmaceuticals (AGIO) in Q4 2020, closing a stake of 3,171 shares — an estimated $111K sold.

Arthur M. Cohen & Associates first reported a position in AGIO in Q3 2014 and held it in 9 quarters. The position peaked at $641K in Q2 2018. 201 funds tracked by Wall St. Rank hold AGIO as of Q4 2020.

Arthur M. Cohen & Associates reported no remaining Agios Pharmaceuticals position as of Q4 2020 after selling out during the quarter.
Arthur M. Cohen & Associates sold 3,171 Agios Pharmaceuticals shares in Q4 2020, an estimated $111K.
Arthur M. Cohen & Associates first reported a position in Agios Pharmaceuticals in Q3 2014 and held it in 9 quarters.
Arthur M. Cohen & Associates's Agios Pharmaceuticals position peaked at $641K in Q2 2018.
201 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q4 2020.

Based on Arthur M. Cohen & Associates's 13F filing for Q4 2020, filed 20 Jan 2021.